Aβ peptide1-42, Tau protein and S-100B protein level in cerebrospinal fluid of three patients with primary progressive aphasia

Neuroscience Letters

Volumn 333, Issue 1, 2002, Pages 33-36

  Maeck, Lienhard ^a   Meller, Johannes ^a   Otto, Markus ^a   Stiens, Gerthild ^b   Wiltfang, Jens ^a   Stoppe, Gabriela ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

A peptide1 42; Primary progressive aphasia; S 100B protein; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN S100B; TAU PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); NERVE GROWTH FACTOR; PEPTIDE FRAGMENT; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADULT; AGED; ARTICLE; BRAIN RADIOGRAPHY; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; SCALE UP; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; AMYLOID BETA-PROTEIN; APHASIA, PRIMARY PROGRESSIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PEPTIDE FRAGMENTS; S100 PROTEINS; TAU PROTEINS;

EID: 0037110451     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00968-0     Document Type: Article

References (14)

1. Black S.E. Focal cortical atrophy syndromes. Brain Cogn. 31:1996;188-229.
2. Green J., Morris J.C., Sandson J., McKeel D.W. Jr, Miller J.W. Progressive aphasia: a precursor of global dementia? Neurology. 40:1990;423-429.
3. Hulstaert F., Blennow K., Ivanoiu A., Schoonderwaldt H.C., Riemenschneider M., deDeyn P.P., Bancher C., Cras P., Wiltfang J., Mehta P.D., Iqbal K., Pottel H., Vanmechele E., Vanderstichele H. Improved discrimination of AD patients using beta-amyloid (1-42) and tau levels in CSF. Neurology. 52:1999;1555-1562.
4. Kertesz A., Munoz D.G. Primary progressive aphasia. Clin. Neurosci. 4:1997;95-102.
5. Mesulam M.M. Primary progressive aphasia. Ann. Neurol. 49:2001;425-432.
6. Mesulam M.M. Primary progressive aphasia - differentiation from Alzheimer's disease. Ann. Neurol. 22:1987;532-534.
7. Mesulam M.M. Slowly progressive aphasia without generalized dementia. Ann. Neurol. 11:1982;592-598.
8. Mesulam M.M., Johnson N., Grujic Z., Weintraub S., Apolipoprotein E. genotypes in primary progressive aphasia. Neurology. 49:1997;51-55.
9. Mesulam M.M., Weintraub S. Heterogeneity in Alzheimer's disease. Boller F., Forcette F., Khachaturia Z., Poncet M., Christen Y., Primary Progressive Aphasia: Sharpening the Focus on a Clinical Syndrome. 1992;43-66 Springer, Berlin.
10. Miller B.L., Gearhart R. Neuroimaging in the diagnosis of frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 10:(Suppl. 1):1999;71-74.
11. Miller B.L., Ikonte C., Ponton M., Levy M., Boone K., Darby A., Berman N., Mena I., Cummings J.L. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology. 48:1997;937-942.
12. Otto M., Esselmann H., Schulz-Schaeffer W., Neumann M., Schroter A., Ratzka P., Cepek L., Zerr I., Steinacker P., Windl O., Kornhuber J., Kretzschmar H.A., Poser S., Wiltfang J. Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jacob disease. Neurology. 54:2000;1099-1102.
13. Otto M., Wiltfang J., Schütz E., Zerr I., Otto A., Pfahlberg A., Gefeller O., Uhr M., Giese A., Weber T., Kretzschmar H.A., Poser S. Diagnosis of Creutzfeldt-Jacob disease by measurement of S100 protein in serum: prospective case-control study. Br. Med. J. 316:1998;577-582.
14. Westbury C., Bub D. Primary progressive Aphasia: a review of 112 cases. Brain Lang. 60:1997;381-406.